Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Peglion, JL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 30 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dolle, F; Valette, H; Hinnen, F; Demphel, S; Bramoulle, Y; Peglion, JL; Crouzel, C
      Highly efficient synthesis of [C-11]S12968 and [C-11]S12967, for the in vivo imaging of the cardiac calcium channels using PET

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    2. Valette, H; Dolle, F; Guenther, I; Hinnen, F; Fuseau, C; Coulon, C; Peglion, JL; Crouzel, C
      Myocardial kinetics of the C-11-labeled enantiomers of the Ca2+ channel inhibitor S11568: An in vivo study

      JOURNAL OF NUCLEAR MEDICINE
    3. Millan, MJ; Gobert, A; Lejeune, F; Newman-Tancredi, A; Rivet, JM; Auclair, A; Peglion, JL
      S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    4. Millan, MJ; Dekeyne, A; Papp, M; La Rochelle, CD; Macsweeny, C; Peglion, JL; Brocco, M
      S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    5. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Adhumeau, A; Brocco, M; Nicolas, JP; Boutin, JA; Despaux, N; Peglion, JL
      S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    6. Millan, MJ; Brocco, M; Rivet, JM; Audinot, V; Newman-Tancredi, A; Maiofiss, L; Queriaux, S; Despaux, N; Peglion, JL; Dekeyne, A
      S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine,and 11 other antipsychotic agents

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    7. DOLLE F; VALETTE H; HINNEN F; FUSEAU C; PEGLION JL; CROUZEL C
      SYNTHESIS AND CHARACTERIZATION OF A C-11 LABELED DERIVATIVE OF S12968- AN ATTEMPT TO IMAGE IN-VIVO BRAIN CALCIUM CHANNELS

      Nuclear medicine and biology
    8. COSSY J; POITEVIN C; PARDO DG; PEGLION JL; DESSINGES A
      SYNTHESIS OF SPIRO[QUINOLINE-2,4'-PIPERIDINES] - HECK VERSUS RADICAL REACTION

      Tetrahedron letters
    9. MILLAN MJ; NEWMANTANCREDI A; BROCCO N; GOBERT A; LEJEUNE F; AUDINOT V; RIVET JM; SCHREIBER R; DEKEYNE A; SPEDDING M; NICOLAS JP; PEGLION JL
      S-18126 4-(2,3-DIHYDROBENZO[1,4]DIOXIN-6-YL)PIPERAZIN-1-YL METHYL]INDAN-2-YL)), A POTENT, SELECTIVE AND COMPETITIVE ANTAGONIST AT DOPAMINE D-4 RECEPTORS - AN IN-VITRO AND IN-VIVO COMPARISON WITH L-745,870 YL]PIPERAZIN-1-YL)METHYL-1H-PYRROLO[2,3B]PYRIDINE) AND RACLOPRIDE

      The Journal of pharmacology and experimental therapeutics
    10. COSSY J; POITEVIN C; PARDO DG; PEGLION JL; DESSINGES A
      SYNTHESIS OF SPIRO[BENZAZEPINE-2,4'-PIPERIDINE]

      Journal of organic chemistry
    11. DOLLE F; HINNEN F; VALETTE H; FUSEAU C; DUVAL R; PEGLION JL; CROUZEL C
      SYNTHESIS OF 2 OPTICALLY-ACTIVE CALCIUM-CHANNEL ANTAGONISTS LABELED WITH C-11 FOR IN-VIVO CARDIAC PET IMAGING

      Bioorganic & medicinal chemistry
    12. PEGLION JL; VIAN J; GOUMENT B; DESPAUX N; AUDINOT V; MILLAN MJ
      TETRACYCLIC ANALOGS OF [-S14297 - SYNTHESIS AND DETERMINATION OF AFFINITY AND SELECTIVITY AT CLONED HUMAN DOPAMINE D-3 VS D-2 RECEPTORS(])

      Bioorganic & medicinal chemistry letters
    13. DUVAL D; HENNIG P; BOUCHET JP; VIAN J; PEGLION JL; VOLLAND JP; PLATZER N; GUILHEM J
      STEREOCHEMICAL STUDY OF A BRADICARDISANT BENZAZEPINE-TYPE DRUG - X-RAY STRUCTURE OF THE CHLORIDE SALT AND HIGH-FIELD NMR-STUDY OF THE STEREOCHEMISTRY IN SOLUTION

      Magnetic resonance in chemistry
    14. COSSY J; POITEVIN C; PARDO DG; PEGLION JL
      AN EASY AND EFFICIENT ACCESS TO 2-BROMO-4-METHOXYANILINE

      Synthetic communications
    15. MILLAN MJ; HJORTH S; SAMANIN R; SCHREIBER R; JAFFARD R; DELADONCHAMPS B; VEIGA S; GOUMENT B; PEGLION JL; SPEDDING M; BROCCO M
      S-15535, A NOVEL BENZODIOXOPIPERAZINE LIGAND OF SEROTONIN (5-HT)(1A) RECEPTORS .2. MODULATION OF HIPPOCAMPAL SEROTONIN RELEASE IN RELATION TO POTENTIAL ANXIOLYTIC PROPERTIES

      The Journal of pharmacology and experimental therapeutics
    16. THOLLON C; BIDOUARD JP; CAMBARRAT C; LESAGE L; REURE H; DELESCLUSE I; VIAN J; PEGLION JL; VILAINE JP
      STEREOSPECIFIC IN-VITRO AND IN-VIVO EFFECTS OF THE NEW SINUS NODE INHIBITOR (-S-16257())

      European journal of pharmacology
    17. MILLAN MJ; PEGLION JL; LAVIELLE G; PERRINMONNEYRON S
      5-HT2C RECEPTORS MEDIATE PENILE ERECTIONS IN RATS - ACTIONS OF NOVEL AND SELECTIVE AGONISTS AND ANTAGONISTS

      European journal of pharmacology
    18. HASCOET M; BOURIN M; PAYEUR R; LOMBET A; PEGLION JL
      SIGMA-LIGAND S14905 AND LOCOMOTOR-ACTIVITY IN MICE

      European neuropsychopharmacology
    19. GAZEAU MC; SIMALTY M; VALAT P; WINTGENS V; KOSSANYI J; DOIZI D; SALVETAT G; JARAUDIAS J; PERLY B; VIAN J; PEGLION JL
      STRUCTURE OF THE INTERMEDIATE FORMED IN THE SYNTHESIS OF SYMMETRICAL PYRYLIUM IONS

      Journal of physical organic chemistry
    20. COSSY J; POITEVIN C; PARDO DG; PEGLION JL
      SYNTHESIS OF 2-(ALKYLAMINO)BENZONITRILES FROM ALPHA-(BROMOARYLAMINO)NITRILES

      Synthesis
    21. NEWMANTANCREDI A; AUDINOT V; JACQUES V; PEGLION JL; MILLAN MJ
      [H-3](-14297 - A NOVEL, SELECTIVE RADIOLIGAND AT CLONED HUMAN DOPAMINE D-3 RECEPTORS()S)

      Neuropharmacology
    22. MILLAN MJ; PEGLION JL; VIAN J; RIVET JM; BROCCO M; GOBERT A; NEWMANTANCREDI A; DACQUET C; BERVOETS K; GIRARDON S; JACQUES V; CHAPUT C; AUDINOT V
      FUNCTIONAL CORRELATES OF DOPAMINE D-3 RECEPTOR ACTIVATION IN THE RAT IN-VIVO AND THEIR MODULATION BY THE SELECTIVE ANTAGONIST, (-S-14297 .1. ACTIVATION OF POSTSYNAPTIC D-3, RECEPTORS MEDIATES HYPOTHERMIA, WHEREAS BLOCKADE OF D-2 RECEPTORS ELICITS PROLACTIN SECRETION AND CATALEPSY())

      The Journal of pharmacology and experimental therapeutics
    23. GOBERT A; RIVET JM; AUDINOT V; CISTARELLI L; SPEDDING M; VIAN J; PEGLION JL; MILLAN MJ
      FUNCTIONAL CORRELATES OF DOPAMINE D-3, RECEPTOR ACTIVATION IN THE RATIN-VIVO AND THEIR MODULATION BY THE SELECTIVE ANTAGONIST, (-S-14297 .2. BOTH D-2 AND SILENT D-3 AUTORECEPTORS CONTROL SYNTHESIS AND RELEASEIN MESOLIMBIC, MESOCORTICAL AND NIGROSTRIATAL PATHWAYS())

      The Journal of pharmacology and experimental therapeutics
    24. PEGLION JL; CANTON H; BERVOETS K; AUDINOT V; BROCCO M; GOBERT A; LEMAROUILLEGIRARDON S; MILLAN MJ
      CHARACTERIZATION OF POTENT AND SELECTIVE ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS IN A SERIES OF N4-SUBSTITUTED ARYLPIPERAZINES

      Journal of medicinal chemistry
    25. LEONCE S; PIERRE A; PEREZ V; GUILBAUD N; KRAUSBERTHIER L; GENTON A; LOMBET A; PEGLION JL; ATASSI G
      MULTIDRUG-RESISTANCE CIRCUMVENTION AND INHIBITION OF [H-3] AZIDOPINE PHOTOLABELING OF P-GLYCOPROTEIN BY NEW DIHYDROPYRIDINE DERIVATIVES DISPLAYING A LOW-AFFINITY FOR CALCIUM CHANNELS

      International journal of oncology
    26. KRAUSBERTHIER L; GUILBAUD N; PEGLION JL; LEONCE S; LOMBET A; PIERRE A; ATASSI G
      IN-VIVO REVERSAL OF MULTIDRUG-RESISTANCE BY 2 NEW DIHYDROPYRIDINE DERIVATIVES, S16317 AND S16324

      Acta oncologica
    27. MILLAN MJ; CANTON H; GOBERT A; LEJEUNE F; RIVET JM; BERVOETS K; BROCCO M; WIDDOWSON P; MENNINI T; AUDINOT V; HONORE P; RENOUARD A; LEMAROUILLEGIRARDON S; VERRIELE L; GRESSIER H; PEGLION JL
      NOVEL BENZODIOXOPIPERAZINES ACTING AS ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS AND AS AGONISTS AT 5-HT1A AUTORECEPTORS - A COMPARATIVE PHARMACOLOGICAL CHARACTERIZATION WITH PROPOSED 5-HT1A ANTAGONISTS

      The Journal of pharmacology and experimental therapeutics
    28. RIVET JM; AUDINOT V; GOBERT A; PEGLION JL; MILLAN MJ
      MODULATION OF MESOLIMBIC DOPAMINE RELEASE BY THE SELECTIVE DOPAMINE-D-3 RECEPTOR ANTAGONIST, (-S-14297())

      European journal of pharmacology
    29. MILLAN MJ; AUDINOT V; RIVET JM; GOBERT A; VIAN J; PROST JF; SPEDDING M; PEGLION JL
      S-14297, A NOVEL SELECTIVE LIGAND AT CLONED HUMAN DOPAMINE-D-3 RECEPTORS, BLOCKS 7-OH-DPAT-INDUCED HYPOTHERMIA IN RATS

      European journal of pharmacology
    30. THOLLON C; CAMBARRAT C; VIAN J; PROST JF; PEGLION JL; VILAINE JP
      ELECTROPHYSIOLOGICAL EFFECTS OF S-16257, A NOVEL SINOATRIAL NODE MODULATOR, ON RABBIT AND GUINEA-PIG CARDIAC PREPARATIONS - COMPARISON WITHUL-FS-49

      British Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 12:27:32